Screener
Vor Biopharma VOR Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
| (in thousands, except share and per share amounts) | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 657,170 | 628,438 |
| Stockholders’ deficit(1): | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 0 shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 800,000,000 and 400,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; 54,185,582 and 38,720,196 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 19 | 18 |
| Additional paid-in capital | 1,222,823 | 988,604 |
| Accumulated other comprehensive (loss) income | (706) | 41 |
| Accumulated deficit | (1,372,560) | (1,152,975) |
| Total stockholders’ deficit | (150,424) | (164,312) |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Vor Biopharma's common stock?
- Vor Biopharma (VOR) reported common stock of $19K in Q1 2026.
- How has Vor Biopharma's common stock changed year-over-year?
- Vor Biopharma's common stock increased by 46.2% year-over-year, from $13K to $19K.
- What is the long-term trend for Vor Biopharma's common stock?
- Over 5 years (2020 to 2025), Vor Biopharma's common stock has grown at a 78.3% compound annual growth rate (CAGR), from $1K to $18K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Vor Biopharma's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude